Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
PLOS Global Public Health|February 4, 2026
Māori and Pacific People's perspectives on Group A Streptococcus vaccine development and delivery in Aotearoa, New ZealandAnneka Anderson, Shivani Fox-Lewis, Cresta-Jane Afoa-Stone, et al.
Radiology|February 13, 2024
Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor TypesMatthias W Wagner, Pejman Jabehdar Maralani, Julie Bennett, et al.
Brain Pathology (Zurich, Switzerland)|October 21, 2019
BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adultsKohei Fukuoka, Yasin Mamatjan, Scott Ryall, et al.
Journal of Immunological Methods|January 18, 2024
Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human seraMartina Carducci, Alana Whitcombe, Luca Rovetini, et al.
The Lancet Regional Health. Western Pacific|June 26, 2025
Capturing the complete clinical spectrum and incidence of severe acute Group A Streptococcus (GAS) disease: a population-based study in Auckland, New ZealandAndrew Fox-Lewis, Kate Wong She, Emma Wong She, et al.
Plos One|May 14, 2024
"Hurts less, lasts longer"; a qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G to prevent rheumatic heart disease in New ZealandJulie Cooper, Stephanie L Enkel, Dhevindri Moodley, et al.
Open Forum Infectious Diseases|August 29, 2024
The Emergence and Impact of the M1UK Lineage on Invasive Group A Streptococcus Disease in Aotearoa New ZealandAnna Vesty, Xiaoyun Ren, Prachi Sharma, et al.
Neuro-Oncology Advances|May 12, 2025
Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectivesChristianne V Mojica, Thiago Pimentel Muniz, Xin Wang, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic studyJoseph Kado, Sam Salman, Thel K Hla, et al.
JCO Precision Oncology|October 30, 2025
Virtual CNS Tumor Board Rounds Within the Canadian Adolescent and Young Adult Neuro-Oncology NetworkBiren Dave, Mikayla Machado, Robert Siddaway, et al.
Pageof 12